TcLand Expression
TcLand Expression Receives $1.7M to Validate Companion Dx for Rheumatoid Arthritis
The funding will be used primarily to set up a European multi-center clinical trial for the validation of a molecular test to predict non-response to anti-TNF treatment, in particular Remicade.
Celera names Merriweather as SVP and CFO; TcLand Expression appoints Payne as CBO.
Pairings: Dec 22, 2010
Premium
Peter Payne
TcLand Licenses Patents to Develop RA Companion Dx
The French firm also said it has received $564,000 in funding for the project.
Apr 15, 2009
Pairings: Apr 15, 2009
Premium
Apr 10, 2009